First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
Brain cancers are notoriously difficult to treat, with surgery and radiation continuing to be the main options for these malignancies. ...
Brain cancers are notoriously difficult to treat, with surgery and radiation continuing to be the main options for these malignancies. ...
This article was written byFollowSeeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We ...
Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, ...
Driven by domestic inflows and renewed optimism about a potential Fed rate cut in the September meeting, the market has ...
Indian Railway Finance Corporation Share Price216.3203:59 PM | 15 July 2024-1.12(-0.52%)One97 Communications Share Price469.6503:59 PM | 15 July 20243.7(0.8%)YES Bank ...
Chakri Lokapriya, Managing Partner, RSB LLP, says paint stocks at best are a trade because they have corrected very significantly ...
Stock market LIVE updates on May 14, 2024: Indian stock markets, which opened higher on Tuesday, were off highs ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.